Learn more

TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO LTD

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    60,828
  • Filing trend
    ⇩ 20.0%
About

TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO LTD has a total of 27 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2014. It filed its patents most often in Taiwan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SILENSEED LTD, MJ BIOLOG INC and GENETHOR GMBH.

Patent filings in countries

World map showing TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO LTDs patent filings in countries

Patent filings per year

Chart showing TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Cheng Han-Chung 18
#2 Tu Chi-Tang 18
#3 Yang Shun-Chieh 8
#4 Wang Yi-Chuang 4
#5 Shen Man-Ching 4
#6 Liu Szu-Ting 4
#7 Tu Chi Tang 3
#8 Lee Yun 3
#9 Cheng Han Chung 2
#10 Harn Horng-Jyh 2

Latest patents

Publication Filing date Title
TW202102240A USE OF EMBLICA EXTRACTION IN PREPARINGPHARMACEUTICAL COMPOSITION FOR REDUCING PRODUCTION OF AMYLOID β-40 ASSOCIATED WITH NEURODEGENERATIVE DISEASE
TW202043462A A culture composition and an use for improving the function of mitochondria thereof
TW202034931A Use of mitochondria for the manufacture of a medicament for treating alzheimer's disease
TW202027763A The composition for treating multiple system atrophy
TW202023595A Use of an extract of emblica officinalis for relieving hangover or preventing a disease causing by alcohol or metabolites thereof
TW202023382A Freeze-preserving agent and freeze preservation method of mitochondria using the same
TW202012617A Serum-free culture medium and stem cell isolation and expansion method using the same in vitro
TW201938182A Use of a ganoderma extract in manufacturing a pharmaceutical composition for increasing bioenergetic healthy index and promoting cellular differentiation
TW201914589A Use of a composition in manufacturing a medicament for protecting and repairing mitochondria
TW201914601A Composition for Reducing Metabolic Syndrome and Application Thereof
TW201900199A Use of Phyllanthus emblica extract for the preparation of a pharmaceutical composition for increasing the activity of mitochondria in the liver
TW201900200A Use of emblica extraction in preparing pharmaceutical composition for improving activity of mitochondria from patient of merrf syndrome
TW201834678A Use of emblica extraction in preparing pharmaceutical composition for increasing gdf11 in blood
TW201822779A Use of extraction mixture in preparing pharmaceutical composition for reducing triglyceride production
TW201811357A Use of emblica extract in preparing pharmaceutical composition for protecting mitochondria in retina
TW201740968A Use of bilberry extraction in preparing pharmaceutical composition for protecting and repairing mitochondria,improving an ability of the mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate,increasing spare respiratory
TW201642957A Biological sample divider and biological sample dividing method
TW201720456A Composition of plant extracts for improving stem cell proliferation and protecting and/or improving mitochondrial functions
TW201720452A Plant extracts for improving mitochondrial activity
TW201734202A Method for inducing cells into pre-apoptotic stage and application thereof